Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Evofem Biosciences, Inc. | d529733d8k.htm |
Exhibit 16.1
January 25, 2018
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated January 25, 2018, of EVOFEM Biosciences, Inc. (formerly Neothetics, Inc.) and are in agreement with the statements contained in the third, fourth and fifth paragraphs on page three therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Ernst & Young LLP